All mice treated with NK:BOB1-TCR/IL-15 showed a significant decrease in tumor burden directly after NK cell infusion compared with mice treated with NK:CMV-TCR/IL-15 and non-treated mice (Figures 5C, D). This evidence concerns the gene IL15 and neoplasm.